---
title: "OrbiMed Advisors reports $12.67 million Enliven Therapeutics common stock sale"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290116943.md"
description: "OrbiMed Advisors, a major shareholder in Enliven Therapeutics, disclosed the sale of common stock on June 15, 2026. Specifically, OrbiMed Genesis Master Fund sold 9,086 shares at $45.02, reducing its stake to 245,728 shares. Simultaneously, OrbiMed Private Investments VII sold 272,322 shares at the same price, lowering its holding to 7,388,902 shares."
datetime: "2026-06-17T23:46:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290116943.md)
  - [en](https://longbridge.com/en/news/290116943.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290116943.md)
generator: "portal-rs"
---

# OrbiMed Advisors reports $12.67 million Enliven Therapeutics common stock sale

-   OrbiMed Advisors, a more-than-10% owner of Enliven Therapeutics, disclosed sales of common stock on June 15, 2026. \* OrbiMed Genesis Master Fund sold 9,086 shares at $45.02, cutting its stake to 245,728 shares. \* OrbiMed Private Investments VII sold 272,322 shares at $45.02, reducing its holding to 7,388,902 shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enliven Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000947871-26-000637), on June 17, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [ELVN.US](https://longbridge.com/en/quote/ELVN.US.md)

## Related News & Research

- [Enliven Therapeutics CMO Helen Louise Collins reports disposal of 5,000 common shares worth $293,612.17](https://longbridge.com/en/news/296396127.md)
- [Handelsbanken Fonder AB Buys New Shares in Enliven Therapeutics, Inc. $ELVN](https://longbridge.com/en/news/296460096.md)
- [Exmar announces availability of 2026 half-year results release](https://longbridge.com/en/news/296992548.md)
- [Eiffage announces availability of H1 2026 results report](https://longbridge.com/en/news/297066901.md)
- [Sea CCO, GC Wang Yanjun sells USD 348,094 of common shares](https://longbridge.com/en/news/296895740.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**